Differential expression of Bcl-2 and bax may enhance neuroblastoma survival
- 1 March 2003
- journal article
- Published by Elsevier BV in Journal of Pediatric Surgery
- Vol. 38 (3), 486-491
- https://doi.org/10.1053/jpsu.2003.50085
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Resistance of colon cancer cells to long‐term 5‐fluorouracil exposure is correlated to the relative level of Bcl‐2 and Bcl‐XL in addition to Bax and p53 statusInternational Journal of Cancer, 2002
- High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)Leukemia, 2002
- The Bax/Bcl-2 Ratio Determines the Susceptibility of Human Melanoma Cells to CD95/Fas-Mediated ApoptosisJournal of Investigative Dermatology, 2001
- MycN and IFNγ cooperate in apoptosis of human neuroblastoma cellsOncogene, 1998
- Mitochondrial control of apoptosisImmunology Today, 1997
- Possible Involvement of Bcl-2 Pathway in Retinoid X Receptor Alpha-Induced Apoptosis of HL-60 CellsBiochemical and Biophysical Research Communications, 1997
- Massive Apoptosis Detected by In Situ DNA Nick End Labeling in NeuroblastomaThe American Journal of Surgical Pathology, 1996
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathCell, 1995
- Mechanisms and Functions of Cell DeathAnnual Review of Cell Biology, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990